Mission Magazine - $500,000 to support Phase I clinical drug programs

$500,000 to support Phase I clinical drug programs

August 2011

An anonymous cash gift of $500,000 will help fund the lifesaving research conducted at the CTRC’s Institute for Drug Development through its Phase I clinical research program. Phase I studies offer hope for cancer patients through new investigational anticancer drugs or new combinations of novel therapies. This generous gift will support researchers who study the molecular characteristics of tumors and monitor how these relate to patients’ responses. It will also fund pharmacogenomic studies that show how genes affect a person’s response to drugs. In addition to funding a biorepository that collects tissues to facilitate studies to optimize personalized cancer therapies, this gift will provide support for novel clinical trials designed and conducted by CTRC clinicians, as well as translational studies to identify new drug targets and approaches for optimal cancer treatments.

The Cancer Therapy & Research Center (CTRC) at the UT Health Science Center San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas.

Next article >>

Current Issue Content

E-Subscribe

Back Issues

Current Issue (PDF)

Share this story

Email Print Twitter Facebook MySpace Stumble Digg

More Destinations

Contact Mission

UT Health Science Center
7703 Floyd Curl Dr.
San Antonio, Texas
78229-3900

Updated 5/17/12

Links provided from UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.